TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31904246

Group type: EXPERIMENTAL
Intervention: Water flosser + oscillating‐rotating powered toothbrush (WF)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Oscillating‐rotating powered toothbrush only (OR)
Number of subjects: 70
Study: 30841946

Group type: EXPERIMENTAL
Intervention: Small for gestational age (SGA)
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: Postnatal stunting at 1 year
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: Postnatal stunting at 2 years
Number of subjects: 1208
Study: 28104641

Group type: EXPERIMENTAL
Intervention: Scanner 1 CT/CTA
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Scanner 2 CT/CTA
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Cumulative peak skin dose from multiple CT/CTA scans
Number of subjects: 52

Group type: COMPARATOR
Intervention: Volumetric CT dose index
Number of subjects: 52
Study: 26414587

Group type: EXPERIMENTAL
Intervention: Oral ginger for the first three days of the chemotherapy cycle (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard antiemetic treatment only (Control group, n = 30)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (n = 60)
Number of subjects: 60
Study: 24145626

Group type: EXPERIMENTAL
Intervention: Superior conjunctival autograft (CAU)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Inferior conjunctival autograft (CAU)
Number of subjects: 60
Study: 21703071

Group type: COMPARATOR
Intervention: Control group (no saliva contamination)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Saliva contamination with 1‐second air‐thinning
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Saliva contamination with 10 seconds of air‐drying
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Saliva contamination with reconditioning
Number of subjects: 80
Study: 19627223

Group type: EXPERIMENTAL
Intervention: Clinic-based intervention (on-site counseling session and six telephone counseling sessions over a 3-month period)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (health information brochures, a list of community resources, and a monthly telephone call to confirm contact information)
Number of subjects: 41
Study: 16680254

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg IV at surgical skin closure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dexamethasone 5 mg IV immediately after anesthesia induction
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg IV
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dexamethasone 5 mg IV
Number of subjects: 60
Study: 15590442

Group type: EXPERIMENTAL
Intervention: Phototherapy plus IVIG (500 mg/kg)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Phototherapy alone (control group)
Number of subjects: 112
Study: 12972104

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10-80 mg)
Number of subjects: 16495

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16495

Group type: COMPARATOR
Intervention: Other statins
Number of subjects: 16495

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 16495
Study: 11185637

Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Telmisartan 120 mg
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study: 8874689

Group type: EXPERIMENTAL
Intervention: Educational program for resident physicians (two one‐hour sessions with specially prepared printed materials)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Prompting intervention (fingerstick blood cholesterol determination prior to the patient's clinic visit)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Combination of both interventions
Number of subjects: 384

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 384
Study: 1425897

Group type: EXPERIMENTAL
Intervention: IV injection of soluble salts of acetylsalicylic acid
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: IV injection of indomethacin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rectal administration of indomethacin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Indoprofen
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3887159

Group type: EXPERIMENTAL
Intervention: Propranolol for two weeks before surgery and throughout the first postoperative week
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard postoperative care
Number of subjects: 14
Study: 30265350

Group type: EXPERIMENTAL
Intervention: Manganese oxide (MnO) at 100 mg/kg
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Manganese oxide (MnO) at 50 mg/kg
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Manganese oxide (MnO) at 10 mg/kg
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Manganese nanoparticles (NP‐Mn2O3) at 100 mg/kg
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Manganese nanoparticles (NP‐Mn2O3) at 50 mg/kg
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Manganese nanoparticles (NP‐Mn2O3) at 10 mg/kg
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Reduction of Mn supplementation from 100 mg/kg to 50 or 10 mg/kg
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Reduction of Mn supplementation
Number of subjects: 1080
Study: 29628593

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg diluted in 20 mL normal saline (NS) over 10 min
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Esmolol 1.5 mg/kg diluted in 20 mL normal saline (NS) over 10 min
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline (NS) infusion of 20 mL over 10 min (Control Group)
Number of subjects: 90
Study: 26661403

Group type: EXPERIMENTAL
Intervention: FEC (5-fluorouracil 600 mg/m2, epirubicin 60 mg/m2, cyclophosphamide 600 mg/m2, day 1, every 3 weeks)
Number of subjects: 1055

Group type: COMPARATOR
Intervention: EP (epirubicin 90 mg/m2 and paclitaxel 175 mg/m2, day 1, every 3 weeks)
Number of subjects: 1055

Group type: EXPERIMENTAL
Intervention: FEC
Number of subjects: 1055

Group type: COMPARATOR
Intervention: EP
Number of subjects: 1055
Study: 24767956

Group type: EXPERIMENTAL
Intervention: Relaxing music
Number of subjects: 23

Group type: COMPARATOR
Intervention: Silence (control)
Number of subjects: 23
Study: 22466101

Group type: EXPERIMENTAL
Intervention: Punctal occlusion with silicone plugs
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-preserved artificial tears
Number of subjects: 30
Study: 20168193

Group type: EXPERIMENTAL
Intervention: Motivational interviewing based on the stages of change (MISC) intervention, 3 interventions (1 in person, 2 on the phone).
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 30
Study: 18339797

Group type: EXPERIMENTAL
Intervention: 100% feedback
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Reduced (62% faded) feedback
Number of subjects: 40
Study: 16137355

Group type: EXPERIMENTAL
Intervention: Cardiac arrest group
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Cardiac arrest group (duration >10 min)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 121

Group type: COMPARATOR
Intervention: AMI group
Number of subjects: 121
Study: 12787260

Group type: EXPERIMENTAL
Intervention: Oral nefopam (20 mg)
Number of subjects: 24
Study: 10803490

Group type: EXPERIMENTAL
Intervention: Diltiazem-based treatment strategy
Number of subjects: 10896

Group type: COMPARATOR
Intervention: Conventional treatment strategy (diuretics or beta-adrenergic blockers)
Number of subjects: 10896
Study: 7546987

Group type: EXPERIMENTAL
Intervention: Long term oral anticoagulant treatment
Number of subjects: 3404
Study: 1708859

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 6948541

Group type: EXPERIMENTAL
Intervention: Individual patient education
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Group education
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Written material only
Number of subjects: 39

Group type: COMPARATOR
Intervention: All education groups
Number of subjects: 39
Study: 31048181

Group type: EXPERIMENTAL
Intervention: Grape byproduct (0; 100; 200; and 300 g/kg DM)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Grape byproduct (300 g/kg DM)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Grape byproduct inclusion
Number of subjects: 34
Study: 27854065

Group type: EXPERIMENTAL
Intervention: Daily text message reminders for the first 2 weeks, then once weekly thereafter for 3 months.
Number of subjects: 24
Study: 26062689

Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (GDT) targeting stroke volume variation with an arterial pulse contour cardiac output monitor
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (GDT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (fluid therapy at the discretion of the attending anesthesiologist)
Number of subjects: 40
Study: 25276732

Group type: EXPERIMENTAL
Intervention: Peer support intervention (phone calls from peers from the last three months of pregnancy until two months after delivery)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 100
Study: 22248554

Group type: EXPERIMENTAL
Intervention: Front-only suspension (FS)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Front-and-rear suspension (FRS)
Number of subjects: 7
Study: 19704107

Group type: EXPERIMENTAL
Intervention: Amlodipine-based therapy
Number of subjects: 259

Group type: COMPARATOR
Intervention: Atenolol-based therapy
Number of subjects: 259
Study: 16717477

Group type: COMPARATOR
Intervention: Itopride hydrochloride
Number of subjects: 0
Study: 15595376

Group type: EXPERIMENTAL
Intervention: Lexical form class cues suggestive of adjectives (Experiment 1)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Lexical form class cues suggestive of count nouns (Experiment 2)
Number of subjects: 112
Study: 11246536

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (75 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simvastatin (additional treatment for three months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (patients with total cholesterol > 5.2 mmol/L taking low-dose aspirin)
Number of subjects: 0
Study: 9728805

Group type: EXPERIMENTAL
Intervention: Chemotherapy (specific regimen not detailed), evaluated at baseline, 7 days, 14 days, and 25 days post-treatment.
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pre-treatment values of Hb < or = 9 g/dl in leukemia patients.
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group of 12 healthy age-matched subjects.
Number of subjects: 17
Study: 7995007

Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lisinopril (20 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Enalapril during angiotensin II infusion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lisinopril during angiotensin II infusion
Number of subjects: 8
Study: 2660541

Group type: EXPERIMENTAL
Intervention: MR imaging
Number of subjects: 38

Group type: COMPARATOR
Intervention: Arthrography
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sonography
Number of subjects: 38
Study: 5356549

Group type: EXPERIMENTAL
Intervention: Concurrent infusion of amino-acids and hormones (secretin and pancreozymin)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Administration of amino-acids or hormones individually
Number of subjects: 2
Study: 86003

Group type: EXPERIMENTAL
Intervention: Full-strength milk
Number of subjects: 46

Group type: COMPARATOR
Intervention: Clear fluids until diarrhoea settled, then full-strength milk reintroduced gradually in quarter-strength steps
Number of subjects: 46

Group type: COMPARATOR
Intervention: Clear fluids until diarrhoea settled, then full-strength milk reintroduced immediately
Number of subjects: 46
Study: 31838217

Group type: EXPERIMENTAL
Intervention: Quadrivalent influenza vaccine (QIV)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Trivalent influenza vaccine (TIV)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Both QIV and TIV
Number of subjects: 1200
Study: 30947385

Group type: EXPERIMENTAL
Intervention: Oral healthcare motivation intervention group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no advice)
Number of subjects: 60
Study: 28958435

Group type: EXPERIMENTAL
Intervention: PSS without lumbar support
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: PSS with lumbar support
Number of subjects: 34
Study: 27884849

Group type: EXPERIMENTAL
Intervention: Fistula-based strategy (intervention)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Catheter-based strategy (control)
Number of subjects: 100
Study: 24433434

Group type: EXPERIMENTAL
Intervention: Ipilimumab (doses ranging from 0.3 to 10 mg/kg)
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Ipilimumab
Number of subjects: 499
Study: 23108147

Group type: EXPERIMENTAL
Intervention: High glycemic index diet
Number of subjects: 185

Group type: COMPARATOR
Intervention: Low glycemic index diet
Number of subjects: 185
Study: 19539427

Group type: EXPERIMENTAL
Intervention: Gabapentin (GPT) or Pregabalin (PGB)
Number of subjects: 2422

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2422
Study: 18377458

Group type: EXPERIMENTAL
Intervention: Transcatheter closure (ASO)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Surgical closure (SUR)
Number of subjects: 162
Study: 12671693

Group type: EXPERIMENTAL
Intervention: Epoetin beta (initial dose 150 IU kg(‐1) three times weekly)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 262
Study: 10872533

Group type: EXPERIMENTAL
Intervention: Total carbohydrate intake (% of energy)
Number of subjects: 2084

Group type: EXPERIMENTAL
Intervention: Potato carbohydrates (g)
Number of subjects: 2084

Group type: EXPERIMENTAL
Intervention: Vegetable carbohydrates (g)
Number of subjects: 2084

Group type: EXPERIMENTAL
Intervention: Cereal carbohydrates (g)
Number of subjects: 2084

Group type: EXPERIMENTAL
Intervention: Fruit carbohydrates (g)
Number of subjects: 2084

Group type: EXPERIMENTAL
Intervention: Milk carbohydrates (g)
Number of subjects: 2084
Study: 8887822

Group type: EXPERIMENTAL
Intervention: HiEH/harassed
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: HiNH/harassed
Number of subjects: 57

Group type: COMPARATOR
Intervention: HiEH/nonharassed
Number of subjects: 57

Group type: COMPARATOR
Intervention: LoEH
Number of subjects: 57

Group type: COMPARATOR
Intervention: HiNH/nonharassed
Number of subjects: 57

Group type: COMPARATOR
Intervention: LoNH
Number of subjects: 57
Study: 1402013

Group type: EXPERIMENTAL
Intervention: Hib‐CPS‐T
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hib‐CPS
Number of subjects: 40
Study: 3987788

Group type: COMPARATOR
Intervention: Procyclidine (10 mg) - intravenous administration
Number of subjects: 6

Group type: COMPARATOR
Intervention: Procyclidine (10 mg) - oral administration
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31571412

Group type: EXPERIMENTAL
Intervention: Acipimox 250 mg orally every 6 hours for 7 days
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Acipimox 250 mg
Number of subjects: 35
Study: 28731373

Group type: EXPERIMENTAL
Intervention: SRP plus 1% Metformin Gel (MF)
Number of subjects: 70

Group type: COMPARATOR
Intervention: SRP plus placebo
Number of subjects: 70
Study: 25616607

Group type: EXPERIMENTAL
Intervention: Active azithromycin (1 g) + placebo doxycycline
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Active doxycycline (100 mg twice a day ×7 days) + placebo azithromycin
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Moxifloxacin (400 mg ×7 days)
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Reverse therapy (active doxycycline if first treated with active azithromycin)
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Reverse therapy (active azithromycin if first treated with active doxycycline)
Number of subjects: 490
Study: 23827814

Group type: EXPERIMENTAL
Intervention: Neurofeedback training (fmθ uptraining)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham-neurofeedback training
Number of subjects: 32
Study: 21831714

Group type: EXPERIMENTAL
Intervention: Clinical monitoring alone (CLIN)
Number of subjects: 493

Group type: COMPARATOR
Intervention: Laboratory and clinical monitoring (LAB)
Number of subjects: 493
Study: 19728275

Group type: EXPERIMENTAL
Intervention: 3 mg bromazepam
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 6 mg bromazepam
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 39
Study: 17362252

Group type: EXPERIMENTAL
Intervention: Pru p 3 sensitization in peach-allergic patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Profilin and Bet v 1 sensitization
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Specific IgE determination and BAT using recombinant allergens (rPru p 3)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Natural and recombinant plant allergens
Number of subjects: 30
Study: 15070938

Group type: EXPERIMENTAL
Intervention: Dichloroacetate (DCA)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 9
Study: 11317472

Group type: EXPERIMENTAL
Intervention: MPPG (3 x 150 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9240606

Group type: EXPERIMENTAL
Intervention: Strict glycemic control and tertiary level obstetric care
Number of subjects: 300

Group type: COMPARATOR
Intervention: Routine obstetric care
Number of subjects: 300
Study: 8496526

Group type: EXPERIMENTAL
Intervention: Sustained release propranolol (mean 293 mg/day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sustained release diltiazem (mean 350 mg/day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nifedipine (mean 79 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Active medications (overall)
Number of subjects: 50
Study: 2967183

Group type: EXPERIMENTAL
Intervention: 10 mg bisoprolol (B)
Number of subjects: 87

Group type: COMPARATOR
Intervention: 100 mg metoprolol (M)
Number of subjects: 87
Study: 30380020

Group type: EXPERIMENTAL
Intervention: Optimal Embedded Dynamic Treatment Regime (EDTR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monte Carlo simulation method for power analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extending Treatment Effectiveness of Naltrexone (EXTEND) trial
Number of subjects: 0
Study: 31269457

Group type: EXPERIMENTAL
Intervention: Unhealthy snacks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Healthy snacks
Number of subjects: 100
Study: 28842597

Group type: EXPERIMENTAL
Intervention: Partial sleep deprivation (3 hours sleep)
Number of subjects: 53
Study: 25854443

Group type: EXPERIMENTAL
Intervention: Fentanyl 50 µg and etomidate 0.1 mg/kg
Number of subjects: 52

Group type: COMPARATOR
Intervention: Etomidate 0.1 mg/kg
Number of subjects: 52
Study: 23871500

Group type: EXPERIMENTAL
Intervention: Elective hospital admission
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-admitted group (control)
Number of subjects: 60
Study: 21481280

Group type: EXPERIMENTAL
Intervention: Epirubicin/Vinorelbine (EPI/VNB) - EPI 90 mg/m2 on day 1, VNB 25 mg/m2 on days 1,5 plus G-CSF subcutaneously on days 7-12, cycles every 21 days
Number of subjects: 104

Group type: COMPARATOR
Intervention: Pegylated liposomal doxorubicin/Vinorelbine (PLD/VNB) - PLD 40 mg/m2 on day 1, VNB 30 mg/m2 on days 1, 15, cycles every 4 weeks
Number of subjects: 104
Study: 19111215

Group type: EXPERIMENTAL
Intervention: Warmed fluid irrigation (37 degrees C to 39 degrees C)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Room-temperature fluid irrigation
Number of subjects: 50
Study: 16414394

Group type: EXPERIMENTAL
Intervention: Endovenous laser treatment with a wavelength of 980 nm
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Endovenous laser treatment with a wavelength of 810 nm
Number of subjects: 51

Group type: COMPARATOR
Intervention: Both groups (980 nm and 810 nm)
Number of subjects: 51
Study: 15295150

Group type: EXPERIMENTAL
Intervention: Immersive virtual reality therapy using a laptop PC, joystick, VR helmet, and specially-designed CD-ROM programs (Virtools) for 12 sessions over 25 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group using an old VR helmet and PC Pentium 133 16 Mb RAM for the same therapeutic protocol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Psychotherapy alone
Number of subjects: 30
Study: 11374677

Group type: EXPERIMENTAL
Intervention: Delayed gastric emptying (t1/2 > 192 min) in functional dyspepsia
Number of subjects: 798

Group type: EXPERIMENTAL
Intervention: Delayed gastric emptying (t1/2 > 192 min) in type I diabetes
Number of subjects: 798

Group type: EXPERIMENTAL
Intervention: Upper GI symptoms in patients with delayed gastric emptying
Number of subjects: 798

Group type: EXPERIMENTAL
Intervention: Symptom prevalence and severity
Number of subjects: 798
Study: 9747408

Group type: EXPERIMENTAL
Intervention: d-fenfluramine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8147337

Group type: EXPERIMENTAL
Intervention: Counseling to increase dietary calcium through food consumption to 1500 mg/d (n = 106)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: 1000‐mg/d calcium supplement (n = 109)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo (n = 111)
Number of subjects: 326
Study: 2894546

Group type: EXPERIMENTAL
Intervention: Endotoxin assay
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Bacteraemia
Number of subjects: 473
Study: 29124381

Group type: EXPERIMENTAL
Intervention: Doxorubicin-eluting beads (DEBDOX-TACE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Contrast-enhanced multidetector CT (MDCT)
Number of subjects: 10
Study: 26577034

Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (2 g)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 25913660

Group type: EXPERIMENTAL
Intervention: Conservative treatment (below‐elbow thumb spica cast until radiological signs of union appeared)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Surgical treatment (wrist arthroscopy and percutaneous antegrade screw fixation)
Number of subjects: 38